Oct4 found to be a prognostic marker for digestive cancers

November 22, 2016

(HealthDay)—Octamer-binding transcription factor 4 (Oct4) is a predictive marker for patients with digestive system cancers, according to a review and meta-analysis published online Nov. 7 in the Journal of Gastroenterology and Hepatology.

Zhiqiang Chen, from the First Affiliated Hospital of Nanjing Medical University in China, and colleagues conducted a literature review to identify studies assessing the potential role of Oct4 as a in tumors.

The researchers identified 13 eligible studies that included 1,538 . Elevated Oct4 expression was significantly associated with poor overall survival (pooled hazard ratio [HR], 2.183), disease-free survival (pooled HR, 1.973), and recurrence-free survival (pooled HR, 2.209) in digestive system malignancies. Cancer type, sample size, study quality, and laboratory detection method did not affect the significant prognostic value of Oct4. In addition, Oct4 expression was found to be an independent predictive factor for overall survival (HR, 2.068). There was no significant association between Oct4 and clinicopathological features of digestive system malignancies.

"This study provided evidence of Oct4 and/or its closely-related homolog protein as a factor for patients with digestive system cancers," the authors write. "More large-scale clinical studies on the prognostic value of Oct4 are warranted."

Explore further: Protein kinase Akt identified as arbiter of cancer stem cell fate, paper reports

More information: Full Text (subscription or payment may be required)

Related Stories

Protein kinase Akt identified as arbiter of cancer stem cell fate, paper reports

December 20, 2012
(Medical Xpress)—The protein kinase Akt is a key regulator of cell growth, proliferation, metabolism, survival, and death. New work on Akt's role in cancer stem cell biology from the lab of senior author Honglin Zhou, MD, ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.